Free Trial
NYSE:GMED

Globus Medical (GMED) Stock Price, News & Analysis

Globus Medical logo
$83.58 +0.26 (+0.31%)
(As of 11/20/2024 ET)

About Globus Medical Stock (NYSE:GMED)

Key Stats

Today's Range
$82.35
$83.91
50-Day Range
$69.33
$83.58
52-Week Range
$44.02
$84.87
Volume
1.04 million shs
Average Volume
1.06 million shs
Market Capitalization
$11.38 billion
P/E Ratio
124.75
Dividend Yield
N/A
Price Target
$88.18
Consensus Rating
Moderate Buy

Company Overview

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Globus Medical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
90th Percentile Overall Score

GMED MarketRank™: 

Globus Medical scored higher than 90% of companies evaluated by MarketBeat, and ranked 85th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Globus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.58, and is based on 8 buy ratings, 3 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Globus Medical has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Globus Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Globus Medical are expected to grow by 15.10% in the coming year, from $2.98 to $3.43 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Globus Medical is 124.75, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 123.44.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Globus Medical is 124.75, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 83.57.

  • Price to Earnings Growth Ratio

    Globus Medical has a PEG Ratio of 1.99. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Globus Medical has a P/B Ratio of 2.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Globus Medical's valuation and earnings.
  • Percentage of Shares Shorted

    2.10% of the outstanding shares of Globus Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Globus Medical has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Globus Medical has recently increased by 0.70%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Globus Medical does not currently pay a dividend.

  • Dividend Growth

    Globus Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.10% of the outstanding shares of Globus Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Globus Medical has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Globus Medical has recently increased by 0.70%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Globus Medical has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Globus Medical this week, compared to 7 articles on an average week.
  • Search Interest

    4 people have searched for GMED on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    10 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Globus Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,512,850.00 in company stock.

  • Percentage Held by Insiders

    18.54% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Globus Medical's insider trading history.
Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

GMED Stock News Headlines

Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.
Globus Medical price target raised to $83 from $74 at Morgan Stanley
Globus Medical price target raised to $87 from $78 at BTIG
Truist Financial Sticks to Its Hold Rating for Globus Medical (GMED)
See More Headlines

GMED Stock Analysis - Frequently Asked Questions

Globus Medical's stock was trading at $53.29 at the beginning of 2024. Since then, GMED shares have increased by 56.8% and is now trading at $83.58.
View the best growth stocks for 2024 here
.

Globus Medical, Inc. (NYSE:GMED) issued its earnings results on Tuesday, November, 5th. The medical device company reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.65 by $0.18. The firm's revenue was up 63.1% compared to the same quarter last year.

Top institutional investors of Globus Medical include Janus Henderson Group PLC (5.17%), State Street Corp (2.64%), Wellington Management Group LLP (1.90%) and Geode Capital Management LLC (1.39%). Insiders that own company stock include David D Davidar, Ann D Rhoads, Leslie V Norwalk, Keith W Pfeil, James R Tobin, Dan Lemaitre, Daniel T Scavilla and Kelly Huller.
View institutional ownership trends
.

Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET), Advanced Micro Devices (AMD) and ServiceNow (NOW).

Company Calendar

Last Earnings
11/05/2024
Today
11/20/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/18/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
CUSIP
37957720
Employees
5,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$88.18
High Stock Price Target
$100.00
Low Stock Price Target
$78.00
Potential Upside/Downside
+5.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.58
Research Coverage
12 Analysts

Profitability

Net Income
$122.87 million
Pretax Margin
4.88%

Debt

Sales & Book Value

Annual Sales
$1.57 billion
Cash Flow
$3.72 per share
Book Value
$29.32 per share

Miscellaneous

Free Float
110,922,000
Market Cap
$11.38 billion
Optionable
Optionable
Beta
1.17

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NYSE:GMED) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners